Inhibitory Antibodies
-
F1938 Anti-CD48 Antibody (Regeneron patent anti-CD48)Summary: Anti-CD48 Antibody (Regeneron patent anti-CD48) -
F1937 Anti-CD36 Antibody (Ona Thera Patent Anti-Cd36)Summary: Anti-CD36 Antibody (Ona Thera Patent Anti-Cd36) -
F1936 Anti-CD3 & EpCAM Antibody (Catumaxomab (Catumaxomab (mIgG2a-rat IgG2b))Summary: Anti-CD3 & EpCAM Antibody (Catumaxomab (Catumaxomab (mIgG2a-rat IgG2b)) -
F1935 Anti-CD3 & EpCAM Antibody (Catumaxomab (Catumaxomab (huIgG1-rat IgG2b))Summary: Anti-CD3 & EpCAM Antibody (Catumaxomab (Catumaxomab (huIgG1-rat IgG2b)) -
F1934 Anti-CD20 Antibody (Regeneron patent anti-CD20)Summary: Anti-CD20 Antibody (Regeneron patent anti-CD20) -
F1933 Anti-CD19 Antibody (Duke U. patent anti-CD19)Summary: Anti-CD19 Antibody (Duke U. patent anti-CD19) -
F1932 Anti-CD19 Antibody (Denintuzumab mafodotin)Summary: Anti-CD19 Antibody (Denintuzumab mafodotin) -
F1931 Anti-CAPRIN1 Antibody (Toray patent anti-Caprin-1)Summary: Anti-CAPRIN1 Antibody (Toray patent anti-Caprin-1) -
F1930 Anti-CA9/CAIX Antibody (Girentuximab-MMAE)Summary: Anti-CA9/CAIX Antibody (Girentuximab-MMAE) -
F1929 Anti-BST2/CD317 Antibody (SBI Biotech patent anti-BST2)Summary: Anti-BST2/CD317 Antibody (SBI Biotech patent anti-BST2)